Table 1.
Demographics, symptoms, medications and TEPS scores.
| SSD (n=88) | Controls (n=66) | p value | |
|---|---|---|---|
| % Male | 77% | 47% | p < 0.001 |
| Age (range) | 20.99 (3.55) (16–33) | 22.54 (2.96) (16–32) | p = 0.005 |
| Education (years) | 12.59 (1.70) | 14.27 (2.60) | p < 0.001 |
| TEPS Anticipatory | 4.24 (0.83) | 4.48 (0.57) | p = 0.04 |
| TEPS Consummatory | 4.30 (0.91) | 4.39 (0.70) | p = 0.49 |
| % White | 59% | 52% | p = 0.35 |
| % African-American/Black | 19% | 0% | p < 0.001 |
| % Hispanic | 2% | 11% | p = 0.03 |
| % Other/Multiple Ethnicities | 19% | 38% | p = 0.01 |
| Second Generation Antipsychotic | 81% | ||
| First and Second Generation Antipsychotics | 5% | ||
| Other Psychiatric Medication(s) | 5% | ||
| No Psychiatric Medication | 9% | ||
| BPRS Positive | 2.32 (0.80) | ||
| BPRS Negative | 2.04 (0.85) | ||
| BPRS Depression | 1.84 (0.83) | ||
| SANS | 1.36 (0.64) | ||
| Social Functioning | 2.15 (1.51) | ||
| Work Functioning | 1.72 (1.26) | ||
| Global Functioning | 45.05 (8.23) |
Notes. SSD = schizophrenia spectrum diagnosis; TEPS = Temporal Experience of Pleasure Scale; BPRS = Brief Psychiatric Rating Scale; SANS = Scale for the Assessment of Negative Symptoms.